SureTrader SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

BioVie Inc. (BIVI)

BIVI RSS Feed
Add BIVI Price Alert      Hide Sticky   Hide Intro
Moderator: someconcerns
Search This Board:
Last Post: 1/9/2017 3:28:57 PM - Followers: 27 - Board type: Free - Posts Today: 0

We are an early developmental stage biotechnology company engaged in the discovery, development and commercialization of new classes of broad spectrum antibiotics for gram-negative and gram-positive bacterial infections, including some of the most difficult-to-treat Multi Drug Resistant Bacteria, also called “Superbugs.” Our drug discovery platform currently provides a multi-pronged level understanding of interactions between drug candidates and their bacterial targets and enables us to engineer antibiotics with enhanced characteristics to attack a Drug Resistant Bacteria with a multi-targeted approach. The Company plans on developing eight pharmaceutical compounds. Our drug candidates are in the development stage. Our pharmaceutical compounds originated at Kard Scientific, Inc., a preclinical contract research organization founded by our President Rajah Menon in 2002 and of which Mr. Menon is its principal shareholder. These compounds were composed and formulated by researchers at Kard who then conducted in-vitro studies. On October 3, 2013, Kard and Mr. Menon assigned all of their rights, formulations, and all studies and data related to efflux pump antibiotics to the Company. The candidates have only been studied in cell-based assays (in-vitro), but have not been studied in small animals (in-vivo) or animals with drug resistant bacteria for efficacy, efficiency and toxicity. We currently own all development and marketing rights to our products. We plan on contracting research and development of our technologies to third parties. The Company intends to file patent applications for each of these candidates as studies advance and funds become available. The Company has assigned a priority to the development of NEB-MRSA and NA-MRSA and has designated these as our leading drug candidates.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BIVI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BIVI News: Securities Registration Statement (s-1) 01/19/2017 05:24:15 PM
BIVI News: Amended Quarterly Report (10-q/a) 01/19/2017 05:21:38 PM
BIVI News: Small Company Offering and Sale of Securities Without Registration (d) 01/19/2017 12:58:59 PM
BIVI News: Current Report Filing (8-k) 01/05/2017 06:05:58 AM
BIVI News: Quarterly Report (10-q) 11/16/2016 01:19:18 PM
PostSubject
#328   Hoping to hear at some point about BIVIs someconcerns 01/09/17 03:28:57 PM
#327   Thanks! I found the email but I appreciate Ultimate01 01/05/17 08:45:28 PM
#326   Item 1.01 Entry into a Material Definitive Agreement. someconcerns 01/05/17 03:19:28 PM
#325   shareholder letter. govorchin 01/05/17 11:49:41 AM
#324   Interesting. Thanks! Any links? Ultimate01 01/05/17 10:47:20 AM
#323   they did a deal with aspire govorchin 01/05/17 09:58:02 AM
#322   Accomplished Healthcare Executive Jim Lang Invests and Joins Ultimate01 12/07/16 09:48:53 AM
#321   yes govorchin 12/02/16 04:55:45 PM
#320   BioVie Submits Investigational New Drug Application for BIV201 someconcerns 12/01/16 07:13:30 PM
#319   Gov, Are you referring to the info about someconcerns 12/01/16 07:09:58 PM
#318   new shareholders letter out govorchin 11/29/16 10:33:25 AM
#317   You're welcome someconcerns 11/03/16 11:46:35 AM
#316   thank you very much govorchin 10/06/16 03:47:09 PM
#315   Gov, It is a legitimate email sent to someconcerns 10/05/16 09:18:14 PM
#314   I received an email about a new stock govorchin 10/05/16 07:30:00 PM
#313   Financials now on Yahoo: someconcerns 10/01/16 03:57:08 PM
#312   thanks. i don't have much money in govorchin 09/30/16 09:41:42 AM
#311   In all fairness, there isn't much to read Ultimate01 09/28/16 09:50:10 PM
#310   INTERESTING. Ultimate01 09/28/16 09:47:24 PM
#309   From annual report (p 44) Leo still owns stock: someconcerns 09/28/16 08:04:36 PM
#308   From the annual report (pp 41-42): someconcerns 09/28/16 08:01:14 PM
#307   From the annual report (p 38): someconcerns 09/28/16 07:56:30 PM
#306   From the annual report (p 37): someconcerns 09/28/16 07:53:56 PM
#305   New annual report: someconcerns 09/28/16 05:55:50 PM
#304   Gov, You could well be right about someconcerns 09/09/16 01:45:40 PM
#303   starting to perk right along. I am govorchin 09/09/16 01:33:55 PM
#302   Better formatting in the email from BIVI: someconcerns 09/09/16 11:04:59 AM
#301   BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation someconcerns 09/09/16 10:15:44 AM
#300   NanoAntibiotics Changes Name to BioVie and Welcomes Dr. someconcerns 08/26/16 09:39:49 AM
#299   Nano Antibiotics Inc., NNAB, changed to BioVie Inc., BIVI: Renee 08/05/16 04:52:14 PM
#298   deleted someconcerns 08/04/16 09:06:22 PM
#297   So it appears we have renamed NanoAntibiotis as someconcerns 07/22/16 09:44:13 PM
#295   thanks. it just seems to me that govorchin 07/17/16 09:57:50 AM
#294   Gov, I'm not sure I can parse anything someconcerns 07/17/16 09:16:31 AM
#293   thanks. i just wondered. and HI back govorchin 07/11/16 04:27:57 PM
#292   I believe that Leo is considered an investor MilesTeg 07/11/16 03:02:13 PM
#291   the following appears in slide show on CTIX website: govorchin 07/11/16 12:34:17 PM
#290   Thanks for the heads up! Seems to me Ultimate01 07/08/16 09:33:16 AM
#289   I agree, someconcerns. JPsooner 07/07/16 12:52:41 PM
#288   JP, I plan to hold as well. someconcerns 07/07/16 12:51:27 PM
#287   Thanks - that's a good reminder. I plan JPsooner 07/07/16 12:39:14 PM
#286   BigCat, As a holder for over two someconcerns 07/07/16 12:36:40 PM
#285   New press release: someconcerns 07/07/16 12:27:40 PM
#284   Nice read. Thanks for posting. JPsooner 07/07/16 11:46:01 AM
#283   Great report just released from Biomed BlgCat 07/07/16 09:07:33 AM
#282   Yes, not too much actual facts to build someconcerns 06/27/16 10:26:45 AM
#281   Yes interesting but I would not read too Ultimate01 06/27/16 10:17:24 AM
#280   Interesting how Ehrlich junior retained shares while Menon someconcerns 06/27/16 10:09:22 AM
#279   Based on ihub streamer Nano has 10x more Ultimate01 06/27/16 09:56:18 AM
#278   Thanks! Ultimate01 06/27/16 09:55:07 AM
PostSubject